USPs that matters:

New: Rare Earth-Themefolio

Advanced IPO-Section: Equities & ETF (link)

ETF InfoDataHub

Visit our new ATH Index-Gate

White Label as a Service

IPO InfoDataHub

Short Selling Radar

Powerful & free of charge: Tools 4 WebMaster ...

Tipp: Exclusive Newswire Digest

Info-Hub

Newswire
Directors Dealings
DD i/o
Short Selling Radar
HFAT
WWR
FTT
NewAD
Ratings
Vola-Statistics

Tools

Tools/Apps
Lab

Campus

KnowHow & Education
Advanced Event Calendar Feed
Mentoring & Coaches

Press

FAQ

What's New

Company
- About Us
- Vision/Mission
- IR
- Press
- Career
- Specials
Portfolio
Product
- CFD/FX
- Indices
- Currencies
- Commodities
- Metals
- Stocks & ETFs
- Crypto
- ETP/ETI
- Financial Innovations
Platforms
Institutional/B2B

Home
Terminal
Sinovac Biotech Ltd

Sinovac Biotech Ltd

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

P8696W104

SEDOL

2384520

CIK

0001084201

www.sinovac.com

LEI:

New: Infographics X-Lab

Sinovac Bio is a Member of Themefolio

Covid19-STX

FIGI: BBG000D0D8P5

SVA

Sinovac Biotech Ltd

GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology

PROFILER

BASIC = Free ADVANCED = User Account BUSINESS = Subscription PRIME = Subscription

ENTERPRISE = upon request

PROFILER

BASIC

ADVANCED

BUSINESS

PRIME

AI Insights

Sinovac Bio

Click to initiate

ENTERPRISE

NAME

Sinovac Biotech Ltd

ISIN

AGP8696W1045

TICKER

SVA

MIC

XNAS

REUTERS

SVA.OQ

BLOOMBERG

SVA US

F&G: 64

6.449,93 S&P · 15,83 Vola-Index · 117.399,01 BTC · 1,17041 EURUSD

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

X-OVR
FACTSHEET
PEERGROUP
X-News Explorer
L/S SHORT
STUDY
ROOTS
IT’s ME

FOR INVESTORS

FOR TRADERS

Securities Trading

Knock out & Barriers (IG)

Theme Folio

Long/Short

by Security Type

by Trading Venue

by Exchange

by Country

by GICS

by Sub-Sector

by Super-Sector

Most of the companies listed here are probably familiar to everyone in one way or another. It's not just stock market players who are familiar with BioNTech, AstraZeneca and Moderna, but probably the vast majority of people who were affected by the global coronavirus pandemic between 2020 and 2023. In industry terms, this is a small proportion of the pharmaceutical companies colloquially referred to as biotech stocks. However, the binding criterion for a Themefolio here is not sector affiliation, but that the players have collectively left their fingerprint on the pandemic. The price movements of the past are visual witnesses. The gold-rush mood was then followed by great lethargy. The future will show which of the NewComers will manage to meet the market's expectations.

ID	Company	ISIN	WKN	BB Ticker	RIC Code	Research	About	Factsheet	Website	Bookmark	DEMO	B/S

Themefolio Member

Covid19-STX

AI-generated company profile - Important! Do not accept unchecked

Result of the AI analysis...

The AI's analysis of the content resulted in the following brief summary:

Tip: Registered users of the community can save the snippets in the user account.

Disclaimer:

This summary was created with the help of an AI technology. The goal is to bring out the core message of the company's message. The simplification of the statement can help to grasp the content of the message more quickly. The feature is experimental in nature. Do not use the information without verification. More information about Lab features can be found here.

Caution: Unverified adoption of previously unquality-assured information is not advised.

You have reached the maximum number of queries. Please log in to the user account or try again later.

If you want to use this and other features, follow the "Registration" to create a user account or log in to an existing user account.

If you use the functionality more often, you can register here.

Create user account

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

BARRISTA SMART * AD

P R O D U C T S U G G E S T I O N S

Report a bug

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Page URL

Paste the page URL here

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Important note

You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .

Understood and confirmed *

I would like to continue *

Continue

Submit improvement suggestion/new feature

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

Subject *

e.g. New calculation method for Risk-of-Ruin-Calculator

View/Tool *

This view/tool

Another page/tool

Link to view/tool

View/Tool (specify URL/link)

Description of the proposed change/feedback *

The more comprehensible the description, the faster a feasibility check can be carried out.

General feedback on the view/tool/component/content *

Use this feedback text field for general or supplementary information

Would you use the tool and recommend it if necessary? *

Your opinion is valuable. Feel free to share it with us.

Your opinion is important to us!

FAQ Profile QA Triggered

You are interested

Do you have a request? Get in contact with us

You are already a member?

Who is online? Community stats (Snapshot): 20.732 Visitors - 22.737 Registered members - 11 New registrations (Welcome!)

ayondo® 2025 - Est.: 2008 - Technology provider, social network, trader community and online platform for investors with an affinity for the stock market - Information, data and news network - Multi-award-winning international business model - Proprietary technology - Fintech pioneer and innovation driver for disruptive technologies - Made in Germany | AI First | NextGen-Finovator

Made in Germany

ayondo-prime a²

Useful Links

About Us

Vision/Mission

Imprint

Legal

Data Protection

Cookie Guidelines

Privacy

Contact

MetaTrader 4

MetaTrader 5

ActivTrader

Education

Tools

Product Universe

FAQ

Visual Sitemap

Helpdesk

Fast lane

https://ayon.do/v

https://ayon.do/r

ayondo® - my community, my spirit

Social Media Links

ayondo® is a trademark of RSQ Technology Ventures GmbH ("RSQ"). RSQ is the operator of the Internet presence ayondo.com and its sub-sites. ayondo® as a brand represents a community of interest that is connected via a social network and common interests.

Financial literacy represents a key qualification. A key objective is to promote financial knowledge and financial literacy. The content published on the online portal is aimed at people who are interested in information and education in the field of investment, investing and trading and related topics. As a precautionary measure, we would like to point out that none of the content available on ayondo.com can be interpreted as a recommendation or invitation to buy or sell financial instruments, nor does it constitute any other advisory service. An explicit recommendation to use a particular service, information or financial instruments is not made.

Inasmuch as investment brokerage within the meaning of Section 2 (2) No. 3 of the German Securities Trading Act (WpIG) is provided via the online portal ayondo.com, RSQ acts as a contractually bound broker pursuant to Section 3 (2) WpIG. This service is provided exclusively for the account and under the liability of DonauCapital Wertpapier GmbH, Passauer Str. 5, 94161 Ruderting. In this case, the contractual partner of the customer is exclusively DonauCapital Wertpapier GmbH.

RSQ is entered as a contractually bound intermediary of DonauCapital Wertpapier GmbH in the public register maintained by the Federal Financial Supervisory Authority (BaFin) on the Internet. The register can be viewed at www.bafin.de.

If interested parties wish to take advantage of securities services with reference to CFD or FX trading, there is the option to consider offers from our cooperation partners for this purpose. Provided that this option is used, RSQ will broker trading accounts to the ActivTrades group of companies.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of all retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Consumer information

Imprint

smart.AD